A detailed history of Claret Asset Management Corp transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Claret Asset Management Corp holds 16,281 shares of ELAN stock, worth $334,086. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,281
Previous 10,937 48.86%
Holding current value
$334,086
Previous $115,000 101.74%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$8.1 - $14.3 $43,286 - $76,419
5,344 Added 48.86%
16,281 $232,000
Q1 2025

May 13, 2025

BUY
$10.04 - $12.47 $80 - $99
8 Added 0.07%
10,937 $115,000
Q4 2024

Feb 13, 2025

BUY
$11.63 - $14.67 $883 - $1,114
76 Added 0.7%
10,929 $132,000
Q3 2024

Nov 14, 2024

BUY
$11.85 - $15.47 $675 - $881
57 Added 0.53%
10,853 $159,000
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $139,592 - $199,186
10,796 New
10,796 $156,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $9.73B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.